30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Fred Cohen

Insider profile

Currently holds positions in Rapid Micro Biosystems Inc, CareDx Inc, Veracyte Inc, Progyny Inc and Intellia Therapeutics Inc

Performance

Overall performance
3.3

Performance over holding periods
3.3
30 days 90 days 120 days
Average return 20% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 33% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Director Rapid Micro Biosystems Inc None -
Independent Director CareDx Inc Jan. 1, 2003 -
Independent Director Veracyte Inc Jan. 1, 2013 -
Independent Director Progyny Inc March 1, 2015 -
Independent Director Intellia Therapeutics Inc Jan. 23, 2019 -
Independent Director Genomic Health Inc April 1, 2002 - Nov. 8, 2019
Independent Director Tandem Diabetes Care Inc Jan. 1, 2013 - June 1, 2019
Director BioCryst Pharmaceuticals Inc July 23, 2013 - Jan. 4, 2019
Independent Director Five Prime Therapeutics Inc May 1, 2002 - May 10, 2018
Independent Director Sorrento Tech Inc Sept. 1, 2009 - Oct. 2, 2017
Director IQVIA Holdings Inc May 8, 2007 - Nov. 5, 2015

Fred Cohen's trades of Intellia Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-01-07 2026-01-05 B Purchase
13,763 -47.2%
299.29
US$4,416,024
13,763 -47.2% 299.29 US$4,416,024
2025-06-03 2025-06-03 PrS Proposed sale
89,083
17.46
US$3,981,050
89,083 17.46 US$3,981,050
2020-05-19 2020-05-18 S Sale
9,797 -34.6%
163.94
US$1,689,367
9,797 -34.6% 163.94 US$1,689,367
2020-05-19 2020-05-18 S Sale
35,847 -89.6%
26.79
US$960,320
35,847 -89.6% 26.79 US$960,320
2019-02-26 2019-02-22 S Sale
693 -1.0%
79.57
US$55,142
693 -1.0% 79.57 US$55,142
2019-02-26 2019-02-22 S Sale
9,307 -12.0%
78.80
US$733,417
9,307 -12.0% 78.80 US$733,417